| pubmed-article:11703220 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11703220 | lifeskim:mentions | umls-concept:C0027424 | lld:lifeskim |
| pubmed-article:11703220 | lifeskim:mentions | umls-concept:C0035457 | lld:lifeskim |
| pubmed-article:11703220 | lifeskim:mentions | umls-concept:C0296800 | lld:lifeskim |
| pubmed-article:11703220 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:11703220 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:11703220 | pubmed:dateCreated | 2001-11-12 | lld:pubmed |
| pubmed-article:11703220 | pubmed:abstractText | Nasal congestion is the predominant symptom in perennial allergic rhinitis (PAR), and it seems to be mainly related to the late-phase inflammatory events. The present pilot study aimed to evaluate the therapeutic effect exerted by fexofenadine in patients with PAR due to mite allergy. | lld:pubmed |
| pubmed-article:11703220 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11703220 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11703220 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11703220 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11703220 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11703220 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11703220 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11703220 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:11703220 | pubmed:issn | 0105-4538 | lld:pubmed |
| pubmed-article:11703220 | pubmed:author | pubmed-author:CanonicaG WGW | lld:pubmed |
| pubmed-article:11703220 | pubmed:author | pubmed-author:CiprandiGG | lld:pubmed |
| pubmed-article:11703220 | pubmed:author | pubmed-author:MilanesiII | lld:pubmed |
| pubmed-article:11703220 | pubmed:author | pubmed-author:CosentinoCC | lld:pubmed |
| pubmed-article:11703220 | pubmed:author | pubmed-author:MondinoCC | lld:pubmed |
| pubmed-article:11703220 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11703220 | pubmed:volume | 56 | lld:pubmed |
| pubmed-article:11703220 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11703220 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11703220 | pubmed:pagination | 1068-70 | lld:pubmed |
| pubmed-article:11703220 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11703220 | pubmed:meshHeading | pubmed-meshheading:11703220... | lld:pubmed |
| pubmed-article:11703220 | pubmed:meshHeading | pubmed-meshheading:11703220... | lld:pubmed |
| pubmed-article:11703220 | pubmed:meshHeading | pubmed-meshheading:11703220... | lld:pubmed |
| pubmed-article:11703220 | pubmed:meshHeading | pubmed-meshheading:11703220... | lld:pubmed |
| pubmed-article:11703220 | pubmed:meshHeading | pubmed-meshheading:11703220... | lld:pubmed |
| pubmed-article:11703220 | pubmed:meshHeading | pubmed-meshheading:11703220... | lld:pubmed |
| pubmed-article:11703220 | pubmed:meshHeading | pubmed-meshheading:11703220... | lld:pubmed |
| pubmed-article:11703220 | pubmed:meshHeading | pubmed-meshheading:11703220... | lld:pubmed |
| pubmed-article:11703220 | pubmed:meshHeading | pubmed-meshheading:11703220... | lld:pubmed |
| pubmed-article:11703220 | pubmed:meshHeading | pubmed-meshheading:11703220... | lld:pubmed |
| pubmed-article:11703220 | pubmed:meshHeading | pubmed-meshheading:11703220... | lld:pubmed |
| pubmed-article:11703220 | pubmed:meshHeading | pubmed-meshheading:11703220... | lld:pubmed |
| pubmed-article:11703220 | pubmed:meshHeading | pubmed-meshheading:11703220... | lld:pubmed |
| pubmed-article:11703220 | pubmed:meshHeading | pubmed-meshheading:11703220... | lld:pubmed |
| pubmed-article:11703220 | pubmed:meshHeading | pubmed-meshheading:11703220... | lld:pubmed |
| pubmed-article:11703220 | pubmed:meshHeading | pubmed-meshheading:11703220... | lld:pubmed |
| pubmed-article:11703220 | pubmed:meshHeading | pubmed-meshheading:11703220... | lld:pubmed |
| pubmed-article:11703220 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11703220 | pubmed:articleTitle | Fexofenadine reduces nasal congestion in perennial allergic rhinitis. | lld:pubmed |
| pubmed-article:11703220 | pubmed:affiliation | Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy. | lld:pubmed |
| pubmed-article:11703220 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11703220 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11703220 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:11703220 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11703220 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11703220 | lld:pubmed |
